Skip to content
J&J says it plans to end Covid-19 vaccine supply deal with emerging biosolutions

Johnson & Johnson said on Monday it planned to end its Covid-19 vaccine supply agreement with a contract manufacturer Emerging BioSolutions Inc., with the two companies accusing each other of violating the agreement.

J&J notified Emergent last week of its intention to terminate the 2020 manufacturing agreement “based on Emergent’s breaches, including failure to supply the drug substance for the Covid-19 vaccine,” J&J said in a statement. written statement.


Not all news on the site expresses the point of view of the site, but we transmit this news automatically and translate it through programmatic technology on the site and not from a human editor.